The Patent Finder

Akamis Bio Limited

Also on record
Records under this name other than the patents Akamis Bio Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.

Showing 1 to 7 of 7 · Back to Akamis Bio Limited

PatentTitleStatus Expires Confidence
US 10,849,945Oncolytic Adenovirus Encoding a B7 Protein or Active Fragment
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,510,868Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Term ended Apr 21, 2026 · High confidence
Term endedTerm ended Apr 21, 2026High confidence
US 8,158,599Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Ended no later than Oct 6, 2025 · Medium confidence
Term endedEnded no later than Oct 6, 2025Medium confidence
US 9,034,344Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Term ended Sep 10, 2025 · High confidence
Term endedTerm ended Sep 10, 2025High confidence
US 9,115,337Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Term ended Sep 10, 2025 · High confidence
Term endedTerm ended Sep 10, 2025High confidence
US 8,765,463Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Ended no later than May 24, 2025 · Medium confidence
Term endedEnded no later than May 24, 2025Medium confidence
US 9,234,185Chimeric Adenoviruses for Use in Cancer Treatment
Term ended
Term ended May 24, 2025 · High confidence
Term endedTerm ended May 24, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited